In cardio-oncology, a myriad of cardiovascular toxicities can result from cancer therapies,
primarily radiation therapy and pharmacologic cancer therapies [1](Fig. 1). The valves …

Almost 2 million new cancer diagnoses will be made and more than 600,000 cancer deaths
will occur in 2020, the equivalent of 5,000 new cases and 1,600 deaths daily (1). Juxtaposed …

Overlapping commonalities between coronavirus disease of 2019 (COVID-19) and cardio-
oncology regarding cardiovascular toxicities (CVT), pathophysiology, and pharmacology are …

Abstract Coronavirus disease 2019 (COVID‐19) has emerged as a global pandemic and
public health crisis. Increasing waves of intermittent infectious outbreaks have dramatically …

In light of the recent retraction of the New England Journal of Medicine article entitled
“Cardiovascular Disease, Drug Therapy, and Mortality in COVID-19”(Mehra et al., full citation …

In response to the coronavirus disease 2019 (COVID-19) pandemic, the Cardio-Oncology
and Imaging Councils of the American College of Cardiology offers recommendations to …

Opinion statement The COVID pandemic has transformed our approach to patient care,
research, and training in cardio-oncology. While the early phases of the COVID pandemic …

The pathophysiology of some non communicable diseases (NCDs) such as hypertension,
cardiovascular disease (CVD), diabetes, and cancer includes an alteration of the endothelial …

Anti-cancer treatment regimens can lead to both acute-and long-term myocardial injury due
to off-target effects. Besides, cancer patients and survivors are severely …

Purpose of review The coronavirus disease 2019 (COVID-19) pandemic, caused by the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread with …